Oligodendroglioma
📧 Sign up to get email alerts when something new happens for Oligodendroglioma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-27EMA Authorised: Voranigo (vorasidenib) — Les Laboratoires Servier
Voranigo (vorasidenib) from Les Laboratoires Servier has been authorised by the EMA for certain gliomas, including oligodendroglioma and ast…
-
EMA approval · 2026-07-21EMA Authorised: Voranigo (vorasidenib) — Les Laboratoires Servier
Voranigo (vorasidenib) has been authorised in the EU for oligodendroglioma and astrocytoma by Les Laboratoires Servier.
-
EMA approval · 2026-03-18EMA Authorised: Voranigo (vorasidenib) — Les Laboratoires Servier
Voranigo (vorasidenib) has been authorised in the EU for the treatment of oligodendroglioma and astrocytoma, with orphan medicine designatio…
-
FDA approval · 2013-08-15FDA Approved: GLEOSTINE — Supplemental Application (NextSource Biotechnology, LLC)
The FDA approved a supplemental application for Gleostine (lomustine) submitted by NextSource Biotechnology, LLC.